Wulin Liu

Title: Wulin Liu: Innovator in Pharmaceutical Research

Introduction

Wulin Liu is a notable inventor based in Tianjin, China. He has made significant contributions to the field of pharmaceutical research, particularly in the development of innovative compounds for medical applications. His work focuses on enhancing the efficacy of treatments for cardiovascular diseases.

Latest Patents

Wulin Liu holds a patent for "Cycloastragenol monoglucoside, preparation, pharmaceutical composition and application thereof." This invention provides a method for preparing cycloastragenol monoglucoside (CMG), which involves several steps. The process begins with using astragaloside IV or Astragali extracts as raw materials, followed by hydrolysis with hydrolase at a constant temperature. The hydrolysate is then separated using macroporous adsorption resin, leading to the purification and separation of the final product. This compound is particularly valuable in the preparation of medicaments for treating cardiovascular diseases.

Career Highlights

Wulin Liu is affiliated with the Tianjin Institute of Pharmaceutical Research, where he conducts his research and development activities. His innovative approach to pharmaceutical formulations has garnered attention in the scientific community. He has successfully developed a method that not only enhances the therapeutic potential of existing compounds but also contributes to the advancement of cardiovascular treatments.

Collaborations

Wulin Liu collaborates with esteemed colleagues, including Lida Tang and Naxia Zhao. Their combined expertise fosters a productive research environment, leading to groundbreaking discoveries in the pharmaceutical field.

Conclusion

Wulin Liu's contributions to pharmaceutical research, particularly through his patent on cycloastragenol monoglucoside, highlight his role as an innovator in the industry. His work continues to pave the way for advancements in treatments for cardiovascular diseases.